FDA Grants Fast Track Designation to VAD044 for Treatment of Adults With HHT
November 19th 2024Clinical trial analysis results studying VAD-44 in patients with hereditary hemorrhagic telangiectasia (HTT) will be presented at the 2024 American Society of Hematology Annual Meeting & Exposition.
Read More